Condition
Chronic Kidney Disease (Stage 3-4) clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Chronic Kidney Disease (Stage 3-4) clinical trials that are recruiting, at sites in 5 countries (most in United States (2), Egypt (1), France (1)). 1 was first registered in the last 30 days. By phase: Phase 4 (1), Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1New in 30 days
- 5Countries
Newest Chronic Kidney Disease (Stage 3-4) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Synbiotic Therapy for Kidney Function in CKD Stage III-IV | — | Chittagong | Recruiting | Nov 3, 2026 |
| Perirenal SC101 injection to lower blood pressure in resistant hypertension with moderate–severe CKD | Phase 1 | Suzhou, Jiangsu | Recruiting | Mar 19, 2026 |
| Herbal Medicine Use in CKD Patients on Réunion Island | — | Saint-Benoît and 3 other locations | Recruiting | Mar 3, 2026 |
| Phosphate assessment in people with chronic kidney disease | — | Dallas, Texas | Recruiting | Jan 27, 2026 |
| Equol and vascular function in women with CKD | Phase 2 | Aurora, Colorado | Recruiting | Sep 26, 2025 |
| ACE Reno Pico Cell Matrix for reducing proteinuria and supporting kidney function | Phase 4 | Giza, GZ | Recruiting | Sep 23, 2025 |
All recruiting trials (6)
-
Synbiotic Therapy for Kidney Function in CKD Stage III-IV
This study tests whether a synbiotic (probiotics plus prebiotics) can improve kidney function in adults with non-dialysis CKD stage 3-4 compared with a placebo.
-
Perirenal SC101 injection to lower blood pressure in resistant hypertension with moderate–severe CKD
This trial will test whether a single injection of SC101 into the fat around the kidneys can lower blood pressure in adults with resistant hypertension and stage 3–4 chronic kidney disease.
-
Herbal Medicine Use in CKD Patients on Réunion Island
This study tests how common herbal medicine use is among adults with chronic kidney disease (stages 3–5) on Réunion Island and whether it relates to kidney disease progression over a year.
-
Phosphate assessment in people with chronic kidney disease
This study will test how increasing dietary phosphate over three weeks affects blood and urine markers in adults with and without stage 3–4 chronic kidney disease.
-
Equol and vascular function in women with CKD
This study tests whether taking equol for 12 weeks improves vascular function in postmenopausal women with chronic kidney disease.
-
ACE Reno Pico Cell Matrix for reducing proteinuria and supporting kidney function
This trial will test whether taking ACE Reno, a sublingual peptide solution four times daily for 12 weeks, can lower urine protein and help stabilize kidney function in adults with nephropathy or chronic kidney disease.
Related topics
Quick answers
How many Chronic Kidney Disease (Stage 3-4) clinical trials are recruiting right now?
6, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (2 trials), Egypt (1 trial), France (1 trial), China (1 trial), Bangladesh (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.